Jose Silva

And doctor, let's go back to 2004. You just published the journal that essentially doesn't cause cancer. So how does you evolve into, hey, we have patients with cancer or prostatectomy, low testosterone, how do you start treating them with confidence? Or again, it was more or less same situation as when you were treating them before, like just very cautious. How did that process started?

And doctor, right now, I mean, are you treating patients with active prostate cancer, active surveillance? Are you doing them on prostatectomy after radiation therapy?

And doctor, right now, I mean, are you treating patients with active prostate cancer, active surveillance? Are you doing them on prostatectomy after radiation therapy?

And doctor, right now, I mean, are you treating patients with active prostate cancer, active surveillance? Are you doing them on prostatectomy after radiation therapy?

And doctor, in these patients, I mean, you say you are around 20 patients, were they on ADT also or just they weren't getting any treatment for the cancer?

And doctor, in these patients, I mean, you say you are around 20 patients, were they on ADT also or just they weren't getting any treatment for the cancer?

And doctor, in these patients, I mean, you say you are around 20 patients, were they on ADT also or just they weren't getting any treatment for the cancer?

And doctor, for urologists out there that are still skeptical about patients that had prostate cancer, what is your recommendation in terms of starting them in any specific gels versus injections or pills, low doses, or do you just treat them as a normal patient?

And doctor, for urologists out there that are still skeptical about patients that had prostate cancer, what is your recommendation in terms of starting them in any specific gels versus injections or pills, low doses, or do you just treat them as a normal patient?

And doctor, for urologists out there that are still skeptical about patients that had prostate cancer, what is your recommendation in terms of starting them in any specific gels versus injections or pills, low doses, or do you just treat them as a normal patient?

I was there. I was there.

I was there. I was there.

I was there. I was there.

And, Doctor, going back to that active surveillance patient guy, any special considerations in terms of how to treat that PSA? I mean, would you treat it just the same as somebody that is not on testosterone? Or are you a little more concerned if you see that the PSA is going higher faster?

And, Doctor, going back to that active surveillance patient guy, any special considerations in terms of how to treat that PSA? I mean, would you treat it just the same as somebody that is not on testosterone? Or are you a little more concerned if you see that the PSA is going higher faster?

And, Doctor, going back to that active surveillance patient guy, any special considerations in terms of how to treat that PSA? I mean, would you treat it just the same as somebody that is not on testosterone? Or are you a little more concerned if you see that the PSA is going higher faster?

So it would be always good to have a baseline of your testosterone prior to treatment in patients with prostate cancer. I don't think it's being done, or at least I'm not necessarily ordering if the patient doesn't have the symptoms. But if at some point they develop the symptoms, it would be good to have that baseline.

So it would be always good to have a baseline of your testosterone prior to treatment in patients with prostate cancer. I don't think it's being done, or at least I'm not necessarily ordering if the patient doesn't have the symptoms. But if at some point they develop the symptoms, it would be good to have that baseline.

So it would be always good to have a baseline of your testosterone prior to treatment in patients with prostate cancer. I don't think it's being done, or at least I'm not necessarily ordering if the patient doesn't have the symptoms. But if at some point they develop the symptoms, it would be good to have that baseline.

But it matters for the quality of the life of the patient.